China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis

BACKGROUND: Prostate cancer is one of the most common malignant tumors worldwide, and is the third-leading cause of cancer death in men. Nearly 70% of new prostate cancer patients in China are locally advanced or widely metastatic with poor prognosis. Providing active treatment to early stage prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhiguo, Liang, Guoshu, Zhang, Peng, Zhao, Zhongqi, He, Zhongnan, Luo, Fengzhen, Chen, Zhenqing, Yang, Zongke, Zhang, Zhijie, Xia, Tao, Liu, Xin, Zhang, Yong, Ye, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575585/
https://www.ncbi.nlm.nih.gov/pubmed/34804822
http://dx.doi.org/10.21037/tau-21-779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575585/
https://www.ncbi.nlm.nih.gov/pubmed/34804822
http://dx.doi.org/10.21037/tau-21-779

Ejemplares similares